Before taking this medicine

KINERET should be used with caution in certain patient populations, including those with active infections or severe renal impairment.

Key Precautions for KINERET Administration

KINERET should not be initiated in patients with active infections. It is crucial to monitor for hypersensitivity reactions, such as anaphylaxis and angioedema, and discontinue the drug if these occur. It should not be combined with TNF-blocking agents due to an increased risk of serious infections. Regular neutrophil counts are recommended before starting treatment and periodically during use. Caution is advised in elderly patients due to a higher risk of infections. Additionally, KINERET may cause a flare of disease upon discontinuation in patients with NOMID or DIRA, requiring careful management.

Kineret(Anakinra)
Kineret is indicated for Rheumatoid Arthritis and Cryopyrin-Associated Periodic Syndromes.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved